Search results
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 week agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron...
Do Regeneron Pharmaceuticals's (NASDAQ:REGN) Earnings Warrant Your Attention?
Simply Wall St. via Yahoo Finance· 2 years agoLike a puppy chasing its tail, some new investors often chase 'the next big thing', even if that...
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance A Reflection Of Its...
Simply Wall St. via Yahoo Finance· 5 months agoRegeneron Pharmaceuticals' (NASDAQ:REGN) stock up by 1.4% over the past week. Since the market...
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Price Is Out Of Tune With Earnings
Simply Wall St. via Yahoo Finance· 5 months agoWith a price-to-earnings (or "P/E") ratio of 22.9x Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) may...
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Recent Stock Performance Tethered To Its Strong...
Simply Wall St. via Yahoo Finance· 2 years agoMost readers would already be aware that Regeneron Pharmaceuticals' (NASDAQ:REGN) stock increased...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders sold US$7.0m worth of stock suggesting...
Simply Wall St. via Yahoo Finance· 1 year agoIn the last year, many Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders sold a substantial...
Is Regeneron Pharmaceuticals (NASDAQ:REGN) Using Too Much Debt?
Simply Wall St. via Yahoo Finance· 2 years agoWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart...
Does Regeneron Pharmaceuticals (NASDAQ:REGN) Have A Healthy Balance Sheet?
Simply Wall St. via Yahoo Finance· 1 year agoSome say volatility, rather than debt, is the best way to think about risk as an investor, but...
We Think Regeneron Pharmaceuticals (NASDAQ:REGN) Can Stay On Top Of Its Debt
Simply Wall St. via Yahoo Finance· 4 months agoDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is...
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 42% Discount?
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights The projected fair value for Regeneron Pharmaceuticals is US$1,372 based on 2 Stage...